Immune modulatory nanoparticle therapeutics for intracerebral glioma

BACKGROUND. Previously we showed therapeutic efficacy of unprotected miR-124 in preclinical murine models of glioblastoma, including in heterogeneous genetically engineered murine models by exploiting the immune system and thereby negating the need for direct tumor delivery. Although these data were...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neuro Oncol
Glavni autori: Yaghi, Nasser K., Wei, Jun, Hashimoto, Yuuri, Kong, Ling-Yuan, Gabrusiewicz, Konrad, Nduom, Edjah K., Ling, Xiaoyang, Huang, Neal, Zhou, Shouhao, Kerrigan, Brittany C. Parker, Levine, Jonathan M., Fajt, Virginia R., Levine, Gwendolyn, Porter, Brian F., Marcusson, Eric G., Tachikawa, Kiyoshi, Chivukula, Padmanabh, Webb, David C., Payne, Joseph E., Heimberger, Amy B.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
Basic and Translational Investigations
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464307/
https://ncbi.nlm.nih.gov/pubmed/27765835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now198
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items